Tumour Targeting Laboratory
Nhi Huynh has not added Biography.
If you are Nhi Huynh and would like to personalize this page please email our Author Liaison for assistance.
Radiolabelling and preclinical characterization of Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa.
European journal of nuclear medicine and molecular imaging Sep, 2021 | Pubmed ID: 33608805
Bromodomain and extraterminal protein-targeted probe enables tumour visualisation using positron emission tomography.
Chemical communications (Cambridge, England) Mar, 2023 | Pubmed ID: 36809538
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with Zr-labelled CI-8993.
European journal of nuclear medicine and molecular imaging Nov, 2024 | Pubmed ID: 39060374
Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.
European journal of nuclear medicine and molecular imaging Nov, 2024 | Pubmed ID: 39060375
Correction to: Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with Zr-labelled CI-8993.
European journal of nuclear medicine and molecular imaging Nov, 2024 | Pubmed ID: 39186103
Olivia Newton-John Cancer Research Institute
Sadia Quazi1,2,
Nhi Huynh1,
Angela Rigopoulos1,
Alexander McDonald1,3,
Uwe Ackermann3,
Andrew Mark Scott1,2,3,4,
Ingrid Julienne Georgette Burvenich1,2
1Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute,
2School of Cancer Medicine, La Trobe University,
3Department of Molecular Imaging and Therapy, Austin Health,
4Faculty of Medicine, The University of Melbourne
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
Research
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
Education
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. All rights reserved
